Top Stocks To Buy Based on Pattern Recognition: Returns up to 21.36% in 14 Days
Top Stocks To Buy
Top Stocks To Buy. This Options forecast is part of the Options Package, as one of I Know First’s algorithmic trading tools. The full Top 10 Options forecast includes daily predictions for the best options to buy for a total of 20 stocks with bullish and bearish signals:
- Top 10 Call Options
- Top 10 Put Options
Package Name: Options
Recommended Positions: Long
Forecast Length: 14 Days (12/03/2017 – 12/18/2017)
I Know First Average: 9.33%
9 out of 10 option prices in this forecast for the Options Package moved as predicted by the algorithm. TEVA was the top performing prediction with a return of 21.36%. AEO and KSS saw outstanding returns of 16.67% and 10.88%. With these notable trade returns, the package itself registered an average return of 9.33% compared to the S&P 500’s return of 1.81% for the same period.
Teva Pharmaceutical Industries Limited (TEVA) develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. The companys Generic Medicines segment offers generic medicines, such as sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. This segment also develops, manufactures, and sells active pharmaceutical ingredients. The companys Specialty Medicines segment provides branded specialty medicines for use in central nervous system and respiratory indications, as well as the womens health, oncology, and other specialty businesses. Its products in the central nervous system area comprise Copaxone for multiple sclerosis; Azilect for the treatment of Parkinsons disease; Nuvigil for the treatment of excessive sleepiness associated with narcolepsy and certain other disorders; Fentora/Effentora for the treatment of breakthrough pain in opioid-tolerant adult patients with cancer; and Zecuity, a prescription transdermal system for the acute treatment of migraine with or without aura in adults. This segments products in the respiratory market include ProAir, ProAir Respiclick, QVAR, and Duoresp Spiromax for the treatment of asthma and chronic obstructive pulmonary disease, as well as Treanda, Granix, Trisenox, Synribo, Lonquex, Myocet, Eporatio, Tevagrastim/Ratiograstim, and Trisenox products in the oncology market. This segment also offers a portfolio of products in the womens health category, which includes ParaGard, Plan B One-Step, OTC/Rx, Zoely, Seasonique, and Ovaleap, as well as other products. Teva Pharmaceutical Industries Limited (TEVA) has collaboration arrangements with Takeda Pharmaceutical Company Limited, Procter & Gamble Company, Intel, and Regeneron Pharmaceuticals, Inc. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.
Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.
How to interpret this diagram
Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.
